Ausgabe 4/2023
Inhalt (9 Artikel)
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S. Saini
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
Brian Dong, Rita Lusen, Ella Chick, Lisa Kline
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists
Stephen V. Liu, Ivy B. Elkins, Jill Feldman, Sarah B. Goldberg
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
Reva Basho, Megan-Claire Chase
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
Hamdy A. Azim, Samah A. Loutfy, Hatem A. Azim Jr, Nermin S. Kamal, Nasra F. Abdel Fattah, Mostafa H. Elberry, Mohamed R. Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S. Shohdy, Loay Kassem
A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers
Karthik Nagaraja Rao, Ripudaman Arora, Prajwal Dange, Nitin Nagarkar, Antti A. Mäkitie, Luiz P. Kowalski, Avraham Eisbruch, Marc Hamoir, Francisco J. Civantos, Vincent Vander Poorten, Sweet Ping Ng, Sandra Nuyts, Mark Zafereo, Ameya A. Asarkar, Paweł Golusinski, Ohad Ronen, Alfio Ferlito
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Sandhya Mehta, Jipan Xie, Raluca Ionescu-Ittu, Xiaoyu Nie, Winghan J. Kwong
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
Javier Sanchez Alvarez, Mahmoud Jaber, Marie-Hélène Blanchet Zumofen
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Naama Halpern, Ben Boursi, Einat Shacham-Shmueli, Einav Nili Gal-Yam, Ofer Margalit, Talia Golan, Tamar Beller, Gal Strauss, Dafna Yahav, Eyal Leshem